COMMUNIQUÉS West-GlobeNewswire

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/10/2026
WALTHAM, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted one newly- [...]
Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel
01/10/2026
MINNEAPOLIS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]
Arvinas to Present Novel Biomarker Data from the Phase 1 Clinical Trial for ARV-102, a PROTAC LRRK2 Degrader, at the 2026 International Congress of Parkinson’s Disease and Movement Disorders®
01/10/2026
NEW HAVEN, Conn., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that novel [...]
Replimune Announces TUDRIQEV™ Now Available in the U.S. for Advanced Melanoma
01/10/2026
ReplimuneConnect Plus a comprehensive program that provides dedicated support and resources to help eligible patients access TUDRIQEV in the U.S. now live WOBURN, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Replimune Group [...]
Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche
01/10/2026
Subsidiary-Level Investment Provides Capital to Advance Commercialization of the Company’s Antiviral Intellectual Property Portfolio with No Issuance of MGRX Common Stock DALLAS, TEXAS, Oct. 01, 2026 (GLOBE NEWSWIRE [...]
Nutraville Introduces Pineal Guardian Advanced, a Liquid Botanical Formula Designed to Support Pineal Gland and Cognitive Wellness
01/10/2026
Tallmadge, OH, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Nutraville is expanding its healthy-aging portfolio with Pineal Guardian Advanced, a liquid botanical formula that combines 11 nutritional and plant-based ingredients to [...]
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
01/10/2026
Please see enclosed pdf. Attachment 01102026_trading_in_shares_Coloplast_Fonden
Coloplast A/S - Major shareholder announcement
01/10/2026
Major shareholder announcement Reference is made to the press release issued by Coloplast A/S on 4 September 2026 regarding the expected implementation of the generational change in the ultimate ownership of Coloplast A [...]
IBA – TRANSPARENCY NOTIFICATION
01/10/2026
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, October 1, 2026 06:00 PM Summary of the notification IBA (Ion Beam Applications), the world’s leading [...]
IBA SA – NOTIFICATION TRANSPARENCE
01/10/2026
(article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 1 octobre 2026, 18:00 Résumé de la notification IBA (Ion Beam Applications SA), le [...]
NMDP Gala Highlights Financial Challenges Facing Patients in Need of Blood Stem Cell Transplants
01/10/2026
Patient financial assistance requests are up 34% as NMDP and its supporters work to help more families overcome barriers to treatment MINNEAPOLIS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- With demand for financial assistance [...]
Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC)
01/10/2026
LGSOC is a biologically distinct variant of ovarian cancer, with limited treatment options, that is generally less responsive to conventional chemotherapy Results presented in a late-breaking plenary session at IGCS [...]
FDA Grants Fast Track Designation for TRE-515 in Combination with KRAS G12C Inhibitors for the Treatment of Non-Small Cell Lung Cancer
01/10/2026
LOS ANGELES, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today that [...]
Phase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor Agonist-induced Weight Loss
01/10/2026
In a predefined MRI substudy, trevogrumab prevented 70% of muscle loss associated with semaglutide treatment A pre-specified subgroup analysis found that patients meeting the low lean mass definition for sarcopenia had [...]
Bloom Healthcare Brings Its Proven In-Home Care Model to Dallas-Fort Worth Seniors
01/10/2026
Home-based geriatric care model brings personalized primary care to seniors across the region DENVER, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Bloom Healthcare , a passionate team of medical providers specializing in in-home [...]
Michigan Contact Lens Opens 1-800-DRY-EYES Center in Expanded Southfield Facility
01/10/2026
One year after relocating from Oak Park and nearly tripling its floor space, the specialty practice has opened a dedicated center for severe dry eye alongside two stations for teaching patients to handle scleral lenses [...]
Government of Saskatchewan proclaims October Health Literacy Month
01/10/2026
SASKATOON, Saskatchewan, Oct. 01, 2026 (GLOBE NEWSWIRE) -- You trust health information to help you make important decisions. But when medical terms are unfamiliar, information is difficult to find, or advice seems to [...]
HealthEdge Launches Unified AI-Powered Platform to Guarantee Financial Outcomes for Health Plans
01/10/2026
Unified platform combines technology, implementation and operational expertise to reduce administrative costs, lower transformation risk and drive continuous performance improvement BOSTON, Oct. 01, 2026 (GLOBE NEWSWIRE [...]
Amplio Pharma Reports Positive Early Clinical Results for NovoBioJect, Designed to Make the World's Most-Used Rheumatoid Arthritis Drug Work for More Patients
01/10/2026
A single dose of NovoBioJect increased the active form of methotrexate inside patients' immune cells by 38%, a first step toward a potential next-generation first-line treatment for rheumatoid arthritis First clinical [...]

Pages